A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Tropicamide (Mydriacyl)

Anticholinergic class · 7 generic manufacturers · 7 ANDAs filed at FDA.

First FDA approval1959-04-01
Generic availableYes · 7 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$12,388 in CY2024 Part D spend1K claims · 1K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.498/unit
6 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.897
Across all dosage forms in distribution.
Highest NADAC
$2.67
Wide spread — brand-strength NDCs still in market.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Tropicamide used for?

Tropicamide is a Anticholinergic medication tracked in Medicare Part D.

Is there a generic for Tropicamide?

Yes. 7 ANDAs filed at FDA, 7 generic manufacturers currently shipping.

How much does my plan pay for Tropicamide?

Across 329 Part D plans, Tropicamide averages $0.897/unit (NADAC). Lowest available: $0.498/unit. Highest in distribution: $2.67/unit.

Is Tropicamide on the FDA shortage list?

No. Tropicamide is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Anticholinergic6 alternatives in D1
01
Atropine
Brand: ATROPEN Auto-Injector
$4.33Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
02
Atropine Injection,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Atropine Sulfate Injection Usp,
Anticholinergic
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
04
Benztropine
Anticholinergic
$0.067Lowest NADAC
12Generic mfrs
$35.4MCY24 Part D spend
Compare →
05
Glycopyrrolate
Brand: Cuvposa
$0.103Lowest NADAC
35Generic mfrs
$15.4MCY24 Part D spend
Compare →
06
Ipratropium
Brand: Atrovent
$0.099Lowest NADAC
10Generic mfrs
$244.7MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (7 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.